Selectively Promiscuous Opioid Ligands: Discovery of High Affinity/Low Efficacy Opioid Ligands with Substantial Nociceptin Opioid Peptide Receptor Affinity

[Image: see text] Emerging clinical and preclinical evidence suggests that a compound displaying high affinity for μ, κ, and δ opioid (MOP, KOP, and DOP) receptors and antagonist activity at each, coupled with moderate affinity and efficacy at nociceptin opioid peptide (NOP) receptors will have util...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Vinod, Ridzwan, Irna E., Grivas, Konstantinos, Lewis, John W., Clark, Mary J., Meurice, Claire, Jimenez-Gomez, Corina, Pogozheva, Irina, Mosberg, Henry, Traynor, John R., Husbands, Stephen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033651/
https://www.ncbi.nlm.nih.gov/pubmed/24761755
http://dx.doi.org/10.1021/jm401964y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033651/
https://www.ncbi.nlm.nih.gov/pubmed/24761755
http://dx.doi.org/10.1021/jm401964y

Ejemplares similares